Joseph Edelman – ROIV history
- Issuer:
- ROIVANT SCIENCES LTD
- Quarters tracked:
- 11 (Q4 2022 → Q1 2026)
- Current shares:
- 8,285,461
- Current value:
- $229.51M
- Peak shares:
- 8,285,461 (Q1 2026)
- Overall change:
- +318%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 8,285,461 | $229.51M | $27.70 | +300,000 | +4% |
| Q4 2025 | 7,985,461 | $173.28M | $21.70 | +617,000 | +8% |
| Q3 2025 | 7,368,461 | $111.48M | $15.13 | +4,036,996 | +121% |
| Q2 2025 | 3,331,465 | $37.55M | $11.27 | +3,331,465 | +100% |
| Q4 2024 | SOLD | — | — | -847,745 | -100% |
| Q3 2024 | 847,745 | $9.78M | $11.54 | +847,745 | +100% |
| Q4 2023 | SOLD | — | — | -3,819,456 | -100% |
| Q3 2023 | 3,819,456 | $44.61M | $11.68 | +687,720 | +22% |
| Q2 2023 | 3,131,736 | $31.57M | $10.08 | +439,600 | +16% |
| Q1 2023 | 2,692,136 | $19.87M | $7.38 | +710,566 | +36% |
| Q4 2022 | 1,981,570 | $15.83M | $7.99 | — | NEW |